Logo

Aurobindo Pharma Share Price

Aurobindo Pharma (INR)1199.55-48.9   (-3.9%)

Exchange ScripsBSE524804NSEAUROPHARMAISININE406A01037

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Aurobindo Pharma Performance

Market performance
Open price1248.4
High1254.7
Volumes2358646
Prev Close1199.55
Low1183.05
Closing date2025-01-10
Historical performance
1 Year High1592.00
3 Year High1592.00
5 Year High1592.00
1 Year Low958.50
3 Year Low397.20
5 Year Low288.85

Aurobindo Pharma Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
69685
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
22.15
Dividend Yield
Dividend Yield
0.38 %

Aurobindo Pharma Investment Returns

1 Year
6.8%
3 Years
62.7%
5 Years
161.9%
10 Years
105.1%

Aurobindo Pharma Technicals

IndicatorsValueSignal
5-DMA1267.98Bearish
10-DMA1299.42Bearish
20-DMA1272.33Bearish
50-DMA1277.78Bearish
100-DMA1391.24Bearish
200-DMA1314.58Bearish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters1414141414
Foreign Investors11111
Domestic Investors1313131313
Public Investors248474238608244561241930259624
Government11111

Aurobindo Pharma Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income5574290632263808
Operating Profit64004400924707157142
Interest28971405486745
Depreciation15217124461126510554
Profit Before Tax43800261253372773436
Consolidated Net Profit31730192752648253348
Adjusted EPS54334591

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital586586586586
Total Reserves297842267813245174218713
Minority Interest80120-19-9
Total Non-Current Liabilities18089866990318073
Total Liabilities438589392125336331334013
Capital Work in Progress27394449642937624289
Total Assets438589392125336331334013

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities24345238685016533290
Cash Flow from Investing Activities-42560-39778-321165987
Cash Flow from Financing Activitie800418144-29693-13649
Net Cash Inflow / Outflow-102102234-1164425628
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 22.15.
  • 3Y Stock Price CAGR of the stock is 18.7.
  • The stock has a beta of 0.6.
  • In the last financial year, the company had an EBITDA of ₹64004 Million.
  • The company generated revenue of ₹290019 Million in the previous financial year.

Aurobindo Pharma

1199.55-48.9   (-3.9%)

Investment Amount: ₹ 114965
Current Value: ₹ 119955
Performance: 4.3%
P/L: ₹ 4990
Top Gainers
SymbolChange%
NURECA380.7(18%)
CUBEXTUB96.84(16%)
MAZDA1969.9(14%)
ATLASCYCLE112.81(10%)
DNAMEDIA6.99(10%)
Top Losers
SymbolChange%
GTPL130.53(-11%)
GRWRHITECH4286.15(-10%)
AWL291.1(-10%)
SPANDANA405.8(-10%)
JAICORPLTD173(-10%)
DISHTV8.86(-10%)
HARRMALAYA284.45(-9%)
KAMDHENU46.4(-9%)
Similar stocks

Zota Health Care

52.3

994.45

December 12 - January 12

Medico Remedies

28.3

63.14

December 12 - January 12

Brooks Laboratories

26.2

182.06

December 12 - January 12

Bajaj Healthcare

18.8

536.65

December 12 - January 12

Nectar Lifesciences

14.3

38.25

December 12 - January 12

SMS Lifesciences

13.8

1301.8

December 12 - January 12

Blue Jet Healthcare

13.5

571.5

December 12 - January 12

Aarti Pharmalabs

10.5

669.5

December 12 - January 12

Announcing Stock of the Month!

Stock of the Month
Stock of the Month